Loading...
STRUCTURAL BASIS OF TRANSCRIPTION INHIBITION BY FIDAXOMICIN (LIPIARMYCIN A3)
Fidaxomicin is an antibacterial drug in clinical use in treatment of Clostridium difficile diarrhea. The active ingredient of the antibacterial drug fidaxomicin, lipiarmycin A3 (Lpm), functions by inhibiting bacterial RNA polymerase (RNAP). Here, we report a cryo-EM structure of Mycobacterium tuberc...
Na minha lista:
| Udgivet i: | Mol Cell |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6205224/ https://ncbi.nlm.nih.gov/pubmed/29606590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molcel.2018.02.026 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|